T P Blackburn - JoVE Visualize

Showing results (41-50 of 55) with videos related to

Pageof 6

Sort By:

British Journal of Pharmacology|September 1, 1995

Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetronL J Steward, J Ge, K R Bentley, et al.

Journal of Medicinal Chemistry|November 1, 1991

Structure/activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]acetamides: a novel series of potent and selective kappa-opioid agonistsJ J Barlow, T P Blackburn, G F Costello, et al.

Psychopharmacology|January 1, 1993

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like propertiesT P Blackburn, G S Baxter, G A Kennett, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991

Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856J P Hieble, A C Sulpizio, R Edwards, et al.

Journal of Medicinal Chemistry|July 7, 1995

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activityI T Forbes, P Ham, D H Booth, et al.

British Journal of Pharmacology|February 1, 1996

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like propertiesG A Kennett, M D Wood, F Bright, et al.

British Journal of Pharmacology|August 1, 1997

Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizuresN Upton, T P Blackburn, C A Campbell, et al.

Neuropharmacology|April 1, 1997

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonistG A Kennett, M D Wood, F Bright, et al.

Journal of Medicinal Chemistry|December 6, 1996

Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.

Neuropharmacology|August 8, 2001

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxietyM D Wood, C Reavill, B Trail, et al.

Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:

Pageof 6

British Journal of Pharmacology|September 1, 1995

Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetronL J Steward, J Ge, K R Bentley, et al.

Journal of Medicinal Chemistry|November 1, 1991

Structure/activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]acetamides: a novel series of potent and selective kappa-opioid agonistsJ J Barlow, T P Blackburn, G F Costello, et al.

Psychopharmacology|January 1, 1993

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like propertiesT P Blackburn, G S Baxter, G A Kennett, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991

Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856J P Hieble, A C Sulpizio, R Edwards, et al.

Journal of Medicinal Chemistry|July 7, 1995

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activityI T Forbes, P Ham, D H Booth, et al.

British Journal of Pharmacology|February 1, 1996

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like propertiesG A Kennett, M D Wood, F Bright, et al.

British Journal of Pharmacology|August 1, 1997

Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizuresN Upton, T P Blackburn, C A Campbell, et al.

Neuropharmacology|April 1, 1997

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonistG A Kennett, M D Wood, F Bright, et al.

Journal of Medicinal Chemistry|December 6, 1996

Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.

Neuropharmacology|August 8, 2001

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxietyM D Wood, C Reavill, B Trail, et al.

Pageof 6